Position in AZN
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$4,102,997
+$3,578,984 QoQ
Shares Held
21,638
+714.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#417
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Derivatives in AZN
reported options exposure · as of Jun 30, 2026CallValue
$16,914,104
CallShares
89,200
PutValue
$22,602,704
PutShares
119,200
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Walleye Trading LLC holds $52,377,864 across 7 Drug Manufacturers - General names. AZN ranks #4 (7.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BIIB |
Biogen Inc.
|
139,253 | $30,087,003 | |
| 2 | NVO |
Novo Nordisk A S
|
188,647 | $9,043,737 | |
| 3 | MRK |
Merck & Co., Inc.
|
52,971 | $6,806,773 | |
| 4 | AZN |
Astrazeneca PLC
This page
|
21,638 | $4,102,997 | |
| 5 | ABBV |
AbbVie Inc.
|
8,267 | $2,080,307 | |
| 6 | GSK |
GSK plc
|
3,522 | $184,623 | |
| 7 | AMGN |
Amgen Inc
|
200 | $72,424 |
All Filings in AZN
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,102,997 | 21,638 | Shares | Sole | 2026-08-03 | |
| 2026-06-30 | $16,914,104 | 89,200 | Call | Sole | 2026-08-03 | |
| 2026-06-30 | $22,602,704 | 119,200 | Put | Sole | 2026-08-03 | |
| 2026-03-31 | $15,639,546 | 79,300 | Call | Sole | 2026-05-11 | |
| 2026-03-31 | $524,013 | 2,657 | Shares | Sole | 2026-05-11 | |
| 2026-03-31 | $16,073,430 | 81,500 | Put | Sole | 2026-05-11 | |
| No filing history on record for this holder in this stock. | ||||||